ArticleBiomaterials research2026
NEKfla: A Genetically Encoded Förster Resonance Energy Transfer Biosensor for Live-Cell Monitoring of Early NIMA-Related Kinase 7-NLR Family Pyrin Domain Containing 3 Inflammasome Signaling.
Article in Biomaterials research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The NLRP3 inflammasome is a key regulator of inflammatory responses and is increasingly recognized as an important mediator of pathological reactions to diverse chemical, biological, and microenvironmental stimuli. However, most currently available approaches primarily detect downstream or end-stage events, limiting real-time analysis of the early molecular processes that precede inflammasome assembly. Here, we report NEKfla, a genetically encoded Förster resonance energy transfer (FRET)-based biosensor designed to monitor early NEK7-NLRP3-associated signaling in living cells with single-cell spatiotemporal resolution. NEKfla was engineered using full-length NEK7 and NLRP3 linked to a ECFP-YPet FRET pair, and a ΔLRR control sensor was generated to assess interaction-dependent responses. In live-cell and in vitro analyses, NEKfla detected stimulus-dependent increases in FRET in response to lipopolysaccharide and nigericin, responded to pharmacological inhibition by MCC950 and licochalcone B, and visualized dynamic changes associated with NLRP3 oligomerization. The biosensor also functioned in multiple cellular contexts, including macrophage-like cells, and detected signaling changes earlier than a caspase-1 reporter. Together, these findings establish NEKfla as a live-cell platform for tracking proximal inflammasome activation events and support its potential utility in mechanistic studies and cell-based screening of materials or compounds that modulate early NLRP3 inflammasome signaling.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.